Cited by 263Photodynamic Therapy Research StudiesPorphyrin Metabolism and DisordersNanoplatforms for cancer theranostics

Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid

Grant, W.E., MacRobert, Aj, Bown, S.G., Hopper, C., Speight, P.M.·1993·The Lancet

Abstract

Photodynamic therapy with intravenous photosensitising drugs has been shown to be effective in the ablation of superficial cancers, but long-lasting photosensitivity is a serious disadvantage. Similar photosensitivity is a feature of certain types of porphyria. We present the first report of tumour necrosis brought about by photodynamic activation of a temporary endogenous porphyrin accumulation, after an oral dose of the haem precursor, 5-aminolaevulinic acid. In 4 patients, quantitative fluorescence microscopy showed that accumulation of the photoactive intermediate protoporphyrin IX peaked after 4-6 h in 4 oral cavity squamous cell carcinomas, returning to background in 24 h. Irradiation with non-thermal red laser light caused tumour necrosis in 3 patients.

Integrity signals

Registry

Crossref · 10.1016/0140-6736(93)91347-o

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ALA-PDT was shown to be an effective treatment for head and neck cancer, especially for superficial lesions.

    “Moreover, ALA-PDT was shown to be an effective treatment for head and neck cancer, especially for superficial lesions [119].”

Cited by

Sorted by citations

Authors
Grant, W. E., MacRobert, A., Bown, S. G., Hopper, C., & Speight, P. M.
Affiliations
  • University College London (GB)
  • Eastman Dental Hospital (GB)
Venue
The Lancet
Publisher
Elsevier BV
Published
1993-07
Volume
342
Issue
8864
Pages
147-148
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2109966571
Cited by
263
References
0
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 9 · 2012: 6
FWCI
19.62
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
photodynamic therapy, oral cancer, 5-aminolevulinic acid, photosensitization, protoporphyrin IX, endogenous porphyrins, squamous cell carcinoma, tumor necrosis, red laser irradiation, porphyria
MeSH terms
Administration, Oral, Aminolevulinic Acid, Carcinoma, Squamous Cell, Fluorescence, Humans, Mouth Neoplasms, Necrosis, Palliative Care, Photochemotherapy, Protoporphyrins, Photosensitizing Agents, Laser Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review